Compare · PCN pharmacist providers

BCS vs Interface Clinical Services.

Two of the names that come up most often when a Primary Care Network is looking at outsourcing clinical pharmacy. They look similar on the surface — both deliver pharmacist input to UK general practice — but they're built on different models, and the right answer depends on what your PCN is actually trying to buy.

What each is, in plain terms.

Bespoke Clinical Services (BCS) is a managed PCN pharmacist provider. We deliver an end-to-end clinical pharmacy service to Primary Care Networks and GP practices — recruit the pharmacists, embed them in your clinical system, supervise them weekly, deliver the DES service requirements, QA the work and report outcomes monthly. One SLA, one report, one escalation point.

Interface Clinical Services (part of IQVIA) historically focuses on disease-area service delivery — specialist nurse and pharmacist programmes commissioned around specific clinical pathways (often pharma-supported). Their model is project- and pathway-driven rather than a continuous, ARRS-funded PCN pharmacist team.

All claims about Interface here reflect publicly available positioning at time of writing. PCNs should verify directly with each provider before procurement.

Model

What you're commissioning.

  • BCS: continuous PCN pharmacist team, ARRS-funded, supervised from the hub
  • Interface: typically discrete clinical service programmes against defined cohorts
  • BCS: pharmacists embedded in your clinical system (EMIS/SystmOne/Vision)
  • Interface: programme-based delivery, often around a sponsored clinical pathway
  • BCS: single SLA covering the whole pharmacist function
  • Interface: programme-by-programme contracting

Governance & supervision

Who owns the clinical risk.

  • BCS: weekly senior pharmacist supervision evidenced for ARRS audit
  • BCS: structured QA sampling of every pharmacist's clinical work
  • BCS: Cyber Essentials Certified, NHS DSPT compliant
  • Interface: corporate-grade governance via IQVIA; programme-specific clinical leadership
  • Both: GPhC-registered clinicians with documented CPD

ARRS alignment

How the work fits the Network Contract DES.

  • BCS: every role designed against the ARRS schedule for the relevant DES year
  • BCS: supervision and outcomes evidence ready for ICB ARRS audit
  • Interface: programme delivery model — ARRS alignment varies by engagement
  • BCS: monthly outcomes report mapped to IIF and QOF indicators

Reporting

What you get back every month.

  • BCS: BCS Impact Dashboard — reviews completed, monitoring gaps closed, GP time released, target movement
  • BCS: monthly written report plus quarterly review with PCN Clinical Director
  • Interface: programme-level reporting against the specific service KPIs

Which model fits which PCN.

If your PCN wants a continuous, ARRS-funded clinical pharmacy team — supervised, governed and outcome-reported as a managed service — BCS is built for exactly that. The whole operating model is designed around being the PCN's pharmacist function, not a project supplier.

If your PCN wants a discrete clinical service programme around a specific pathway (often with pharma support attached), a programme-based provider may fit better.

Many PCNs run both — a managed pharmacist team for the DES service requirements, plus separately commissioned pathway programmes alongside.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call